HealthQuest Capital supplied $75m for the medical test provider, which counts The Chernin Group as an investor, at a flat $1.3bn valuation.

Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Telus Pollinator Fund for Good is equipped with $76.5m to invest in developers of technology that can promote positive social and environmental impact.

The insurance provider has committed $100m to the Life Science Impact Program, which is managed by Grove Street Advisors and will focus on healthcare businesses.

The sustainable forestry wood provider will use the funding to expand further into East Africa and bolster its wood manufacturing resources.

The insurance firm is set to begin by contributing to a TPG-run fund before moving on to its own investments in three years time.

Axa, BNP Paribas Cardif, CNP Assurances and SG Insurance have backed the investment firm's first regional vehicle, which has already deployed $80m.

Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.

KKR's Gamma Biosciences platform has committed $54.1m in financing to a new subsidiary of Univercells, whose existing investors include Takeda.